ANOVA now offers Platelet-Rich Plasma (PRP)
for Orthopedic Treatments
MONDAY, 6 MAY 2019
ANOVA now offers Platelet-Rich Plasma (PRP) for Orthopedic Treatments
ANOVA Institute for Regenerative Medicine is now offering Platelet-Rich Plasma (PRP) on its own or in combination with other therapies such as Bone Marrow Concentrate (BMC) or hyaluronic acid for the effective treatment of different orthopedic problems.
Platelet-Rich Plasma (PRP) is a blood product derived solely from the patient’s own blood. Besides small solid components (red and white cells, bioactive proteins and growth factors) it has a large number of platelets. Especially the bioactive proteins are shown to play a vital role in tissue healing and hemostasis. PRP can thus be a powerful tool for the treatment of specific orthopedic problems.
Recent scientific work has shown the effectiveness of PRP for osteoarthritis1, tendon regeneration2, nonhealing wounds3 and musculoskeletal conditions4, amongst others.
ANOVA is now offering PRP Treatment alone or in combination with Bone Marrow Concentrate Therapy and other medical therapies for different diseases. At ANOVA, we concentrate the platelets — and with that the concentration of all bioactive compounds —5 to 10 times than usual, and administer it to the patient for it to unfold its healing properties.
News & Insights
Rejuvenation Therapy – An Overview of Anti-Aging Stem Cell Therapies
Rejuvenation therapy is a form of medical treatment with the focus to halt, alter and even reverse the aging process. While there is currently no scientifically proven way to delay our internal aging processes themselves, there are ways to alter or delay some of the effects we experience as we age. Stem cell therapy is on the rise as a rejuvenation treatment. In this article, we discuss the differences between the various stem cell therapies for anti-aging.
What are alternative therapies for Parkinson’s Disease?
Parkinson's Disease (PD) is one of the most common diseases of the nervous system. There is currently no cure for the disease. Common treatments aim at easing symptoms and reducing side effects as much as possible. A big part of the therapy usually includes medication. But are there other options? Can alternative treatments enhance the effect of typical PD therapies, or even stop the progression of the disease? Here we provide an overview of treatment options for PD.
Does stem cell therapy for amyotrophic lateral sclerosis work?
Amyotrophic lateral sclerosis (ALS) is a very serious disease of the central and peripheral nervous system. With the exception of the rare hereditary forms, its cause is still unknown. Even though they are often compared, ALS has nothing to do with MS (Multiple Sclerosis) - they are two completely different diseases.
About one to two out of 100,000 people develop ALS each year. The disease usually begins between the ages of 50 and 70; younger adults are rarely affected. Men are affected slightly more often than women (1.6:1). The frequency of ALS appears to be increasing worldwide. Disease progress varies greatly from patient to patient, and life expectancy is significantly shortened.
Currently, there is no known cure for ALS, but stem cell-based therapies may give patients, their doctors and scientists hope in dealing with this condition.
The Power of Exosomes
The term “exosomes” has frequently been in the news in recent years. They have been known to biologists since their discovery in the 1980s, but they remain something unknown to most other people. As their relevance in the pharmaceutical and medical field increases, we want to explain in simple ways what exosomes are, and why they are disrupting science.
Stem Cell Treatment Improves Degenerative Disc Disease (DDD) and Chronic Back Pain
Degenerative disc disease (DDD) is one of the most common sources of back pain and affects approximately 30 million people every year. It can lead to a chronic debilitating condition and can have a serious negative impact on a person's quality of life. Although several structures within the spine have been identified as sources of pain, the intervertebral disc accounts for approx. 40-50% of all chronic lower back pain. When pain from DDD is severe, traditional non-operative treatment may be ineffective.
Recent research has shown that the injection of bone marrow stem cells into degenerating discs can halt and in some cases even reverse their degeneration. This is important, because this in turn slows down or halts the cascade of secondary problems resulting from a degenerating discs, such as chronic back pain, restricted motion, spinal cord and nerve root compression with radiating pain in arms and legs, deformation and inflammation in vertebral bodies (osteochondrosis), facet joint arthrosis and others.